doi: 10.1021/jm050676a.
Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH
Affiliations
- PMID:16279806
- DOI: 10.1021/jm050676a
Item in Clipboard
Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH
Stephen J Benkovic et al. J Med Chem..
Display options
Format
Display options
Format
Abstract
As bacteria continue to develop resistance toward current antibiotics, we find ourselves in a continual battle to identify new antibacterial agents and targets. We report herein a class of boron-containing compounds termed borinic esters that have broad spectrum antibacterial activity with minimum inhibitory concentrations (MIC) in the low microgram/mL range. These compounds were identified by screening for inhibitors against Caulobacter crescentus CcrM, an essential DNA methyltransferase from gram negative alpha-proteobacteria. In addition, we demonstrate that borinic esters inhibit menaquinone methyltransferase in gram positive bacteria using a new biochemical assay for MenH from Bacillus subtilis. Our data demonstrate the potential for further development of borinic esters as antibacterial agents as well as leads to explore more specific inhibitors against two essential bacterial enzymes.
Similar articles
- The antimicrobial efficacy and structure activity relationship of novel carbohydrate fatty acid derivatives against Listeria spp. and food spoilage microorganisms.Nobmann P, Smith A, Dunne J, Henehan G, Bourke P.Nobmann P, et al.Int J Food Microbiol. 2009 Jan 15;128(3):440-5. doi: 10.1016/j.ijfoodmicro.2008.10.008. Epub 2008 Oct 17.Int J Food Microbiol. 2009.PMID:19012983
- Aryl urea analogs with broad-spectrum antibacterial activity.Seth PP, Ranken R, Robinson DE, Osgood SA, Risen LM, Rodgers EL, Migawa MT, Jefferson EA, Swayze EE.Seth PP, et al.Bioorg Med Chem Lett. 2004 Nov 15;14(22):5569-72. doi: 10.1016/j.bmcl.2004.08.059.Bioorg Med Chem Lett. 2004.PMID:15482926
- Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseases.Baker SJ, Akama T, Zhang YK, Sauro V, Pandit C, Singh R, Kully M, Khan J, Plattner JJ, Benkovic SJ, Lee V, Maples KR.Baker SJ, et al.Bioorg Med Chem Lett. 2006 Dec 1;16(23):5963-7. doi: 10.1016/j.bmcl.2006.08.130. Epub 2006 Sep 25.Bioorg Med Chem Lett. 2006.PMID:16997550
- Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.Mitscher LA.Mitscher LA.Chem Rev. 2005 Feb;105(2):559-92. doi: 10.1021/cr030101q.Chem Rev. 2005.PMID:15700957Review.No abstract available.
- Recent developments in the identification of novel oxazolidinone antibacterial agents.Renslo AR, Luehr GW, Gordeev MF.Renslo AR, et al.Bioorg Med Chem. 2006 Jun 15;14(12):4227-40. doi: 10.1016/j.bmc.2006.01.068. Epub 2006 Mar 9.Bioorg Med Chem. 2006.PMID:16527486Review.
Cited by
- Roles of DNA adenine methylation in host-pathogen interactions: mismatch repair, transcriptional regulation, and more.Marinus MG, Casadesus J.Marinus MG, et al.FEMS Microbiol Rev. 2009 May;33(3):488-503. doi: 10.1111/j.1574-6976.2008.00159.x. Epub 2009 Jan 19.FEMS Microbiol Rev. 2009.PMID:19175412Free PMC article.Review.
- Preclinical and histological study of boron-containing compounds hydrogels on experimental model of periodontal disease.Mitruţ I, Cojocaru MO, Scorei IR, Biţă A, Mogoşanu GD, Popescu M, Olimid DA, Manolea HO.Mitruţ I, et al.Rom J Morphol Embryol. 2021 Jan-Mar;62(1):219-226. doi: 10.47162/RJME.62.1.21.Rom J Morphol Embryol. 2021.PMID:34609424Free PMC article.
- Boric acid inhibits alveolar bone loss in rat experimental periodontitis through diminished bone resorption and enhanced osteoblast formation.Shalehin N, Hosoya A, Takebe H, Hasan MR, Irie K.Shalehin N, et al.J Dent Sci. 2020 Dec;15(4):437-444. doi: 10.1016/j.jds.2019.09.009. Epub 2020 Jan 21.J Dent Sci. 2020.PMID:33505614Free PMC article.
- Comparative Evaluation of Boric Acid Gel versus Chlorhexidine Gel in the Treatment of Chronic Periodontitis: Randomized, Placebo-Controlled Clinical Study.Mamajiwala A, Sethi KS, Mahale SA, Raut CP, Karde PA, Kale AM.Mamajiwala A, et al.Contemp Clin Dent. 2019 Jul-Sep;10(3):457-464. doi: 10.4103/ccd.ccd_752_18.Contemp Clin Dent. 2019.PMID:32308320Free PMC article.
- Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms.Le P, Kunold E, Macsics R, Rox K, Jennings MC, Ugur I, Reinecke M, Chaves-Moreno D, Hackl MW, Fetzer C, Mandl FAM, Lehmann J, Korotkov VS, Hacker SM, Kuster B, Antes I, Pieper DH, Rohde M, Wuest WM, Medina E, Sieber SA.Le P, et al.Nat Chem. 2020 Feb;12(2):145-158. doi: 10.1038/s41557-019-0378-7. Epub 2019 Dec 16.Nat Chem. 2020.PMID:31844194Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials